Improving diuresis and dropsy with elamipretide in advanced heart failure (IDDEA-HF); a multi-centre, double-blind, placebo-controlled trial

Back

HFA Premium Access

Improving diuresis and dropsy with elamipretide in advanced heart failure (IDDEA-HF); a multi-centre, double-blind, placebo-controlled trial

Session: Rapid Fire 3 - Acute heart failure

Topic: Treatment

Speaker: Professor J. Cleland (Glasgow, GB)

Event: Heart Failure 2019

Congress Presentation

Add to my library

About the speaker

Professor John Cleland

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

82 presentations

13 followers

9 more presentations in this session

The discriminative power and optimal diagnostic thresholds of NT-proBNP in patients admitted with acute heart failure-related signs and symptoms: a prospective observational study

Speaker: Doctor P. Simitsis (Athens, GR)

Access

Abstract

Compeering of predictive accuracy for 30, 90 and 365-day Heart Failure readmission assessed by impedance technique and NT-proBNP. Results of IMPEDANCE-HF extended trial

Speaker: Professor M. Kleiner Shochat (Hadera, IL)

BIS equation of glomerular filtration rate in the prediction of hospitalization and mortality in older patients with heart failure

Speaker: Doctor J. Santos (Viseu, PT)

Incident hyperkalemia and RAAS-inhibition during an acute heart failure hospitalization

Speaker: Mr J. Beusekamp (Groningen, NL)

Access

Abstract

Concurrent Initiation of Intra-aortic Balloon Pumping with Extracorporeal Membrane Oxygenation Reduced In-hospital Mortality in Postcardiotomy Cardiogenic Shock

Speaker: Doctor K. Chen (Beijing, CN)

Access the full session

Rapid Fire 3 - Acute heart failure

Speakers: Professor J. Cleland, Doctor P. Simitsis, Professor M. Kleiner Shochat, Doctor J. Santos, Mr J. Beusekamp...

Access

About the event

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources